Pharmaceutical Development Grp is categorized under Industry Specialist Consultants in Tampa, FL and active since 2000.
Pharmaceutical Development Grp was established in 2000, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Industry Specialist Consultants business, which does work in the B2B market, and is classified as a Industry Specialist Consultants, under code number by the NAICS.
If you are seeking more information, feel free to contact Cheryl Blume at the company’s single location by writing to 13902 N Dale Mabry Highway # 230, Tampa, Florida FL 33618 or by phoning (813) 963-3062. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharmaceutical Development Grp |
| Contact Person: | Cheryl Blume |
| Address: | 13902 N Dale Mabry Highway # 230, Tampa, Florida 33618 |
| Phone Number: | (813) 963-3062 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Industry Specialist Consultants |
| Share This Business: |
Pharmaceutical Development Grp was started in 2000 to provide professional Industry Specialist Consultants under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Cheryl Blume for inquiries that concern Pharmaceutical Development Grp by calling the company number (813) 963-3062, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Development Grp can be found at the coordinates 28.07361,-82.50668 as well as the street address 13902 N Dale Mabry Highway # 230 in Tampa, Florida 33618.
For its online presence, you may visit Pharmaceutical Development Grp’s website at and engage with its social media outlets through on Twitter and on Facebook.